Participating practitioners shall submit to the commissioner reports on the use of Schedule I controlled dangerous substances received by their patients pursuant to this act.
N.J. Stat. Ann. § 26:2L-7
Reports by participating practitioners
Known as the Controlled Dangerous Substances Therapeutic Research Act
The act spans §§ 26:2L-1 to 26:2L-9 (9 sections).
L.1981, c. 72, s. 7, eff
Current official text: New Jersey Legislature. Digitized from the New Jersey Legislature bulk statutes download. Reproduced from public-domain New Jersey statutes; confirm against the official source for the current text. Not legal advice.